Century Therapeutics Inc (IPSC) — Cash Flow Quality Index
Latest as of March 2025:
-0.45x
Century Therapeutics Inc (IPSC) has a Cash Flow Quality Index of -0.45x as of March 2025. Operating cash flow of $-34.62 Million is below net income of $76.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Century Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.45x
Operating CF / Net Income
Operating Cash Flow
$-34.62 Million
USD
Net Income
$76.56 Million
USD
Data as of
Mar 2025
Most recent filing
Annual Cash Flow Quality Index for Century Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Century Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.